Unlocking the Potential of Antibody Drug Conjugates: A Revolution in Cancer Treatment

Knowledge Sourcing Intelligence19 Feb, 2024News

Antibody Drug Conjugates are a class of biopharmaceuticals designed to harness the specificity of monoclonal antibodies (mAbs) and the potency of cytotoxic drugs. The concept behind ADCs involves attaching a cytotoxic payload to a monoclonal antibody that selectively targets cancer cells.